3. A Review of the Clinical Development of MenACWY-TT, a Quadrivalent Meningococcal Vaccine Conjugated to Tetanus Toxoid, in Adolescents

por Peyrani, Paula, Webber, Chris, Burman, Cindy, Balmer, Paul, Perez, John L
Publicado 2020

4. MenACWY-TT Long-Term Antibody Persistence Following Adolescent Vaccination and Evaluation of a Booster Dose: A Review of Clinical Data

por Peyrani, Paula, Webber, Chris, Burman, Cindy, Balmer, Paul, Perez, John L
Publicado 2020

2722. Effects of Sex, Age, and Race on Immunogenicity of MenB-FHbp, a Bivalent Meningococcal B Vaccine: A Pooled Evaluation of Clinical Trial Data

por Beeslaar, Johannes, Peyrani, Paula, Maguire, Jason, Eiden, Joseph, Palmer, Paul, Maansson, Roger, Crowther, Graham, Perez, John L
Publicado 2019

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data

por Beeslaar, Johannes, Peyrani, Paula, Absalon, Judith, Maguire, Jason, Eiden, Joseph, Balmer, Paul, Maansson, Roger, Perez, John L.
Publicado 2020

Vaccination strategies for the prevention of meningococcal disease

por Vuocolo, Scott, Balmer, Paul, Gruber, William C., Jansen, Kathrin U., Anderson, Annaliesa S., Perez, John L., York, Laura J.
Publicado 2018

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of...

por Quiambao, Beatriz, Peyrani, Paula, Li, Ping, Cutler, Mark W., Van Der Wielen, Marie, Perez, John L., Webber, Chris
Publicado 2020

1478. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS

por Quiambao, Beatriz, Peyrani, Paula, Webber, Chris, Van Der Wielen, Marie, Bianco, Veronique, Perez, John L, Cutler, Mark W, Li, Ping
Publicado 2019

2722 B. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS

por Quiambao, Beatriz, Peyrani, Paula, Webber, Chris, Van Der Wielen, Marie, Bianco, Veronique, Perez, John L, Cutler, Mark W, Li, Ping
Publicado 2019

Potential impact of the bivalent rLP2086 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease

por Anderson, Annaliesa S., Hao, Li, Jiang, Qin, Harris, Shannon L., Jones, Thomas R., Perez, John L., York, Laura, Eiden, Joseph, Jansen, Kathrin U.
Publicado 2013

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age

por Vesikari, Timo, Peyrani, Paula, Webber, Chris, Van Der Wielen, Marie, Cheuvart, Brigitte, De Schrevel, Nathalie, Aris, Emmanuel, Cutler, Mark, Li, Ping, Perez, John L.
Publicado 2020

6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy...

por Peterson, James, Drazan, Daniel, Czajka, Hanna, Maguire, Jason, Pregaldien, Jean-Louis, Seppa, Ilkka, Maansson, Roger, O’Neill, Robert, Anderson, Annaliesa S, Balmer, Paul, Beeslaar, Johannes, Perez, John L
Publicado 2020

Meningococcal serogroup B vaccines: Estimating breadth of coverage

por Donald, Robert G. K., Hawkins, Julio Cesar, Hao, Li, Liberator, Paul, Jones, Thomas R., Harris, Shannon L., Perez, John L., Eiden, Joseph J., Jansen, Kathrin U., Anderson, Annaliesa S.
Publicado 2016

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactiva...

por Vesikari, Timo, Wysocki, Jacek, Beeslaar, Johannes, Eiden, Joseph, Jiang, Qin, Jansen, Kathrin U., Jones, Thomas R., Harris, Shannon L., O'Neill, Robert E., York, Laura J., Perez, John L.
Publicado 2016

A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

por Borja-Tabora, Charissa Fay Corazon, Peyrani, Paula, Webber, Chris, Van der Wielen, Marie, Cheuvart, Brigitte, De Schrevel, Nathalie, Bianco, Veronique, Aris, Emmanuel, Cutler, Mark, Li, Ping, Perez, John L.
Publicado 2020

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies

por Beeslaar, Johannes, Absalon, Judith, Anderson, Annaliesa S., Eiden, Joseph J., Balmer, Paul, Harris, Shannon L., Jones, Thomas R., O’Neill, Robert E., Pregaldien, Jean-Louis, Radley, David, Maansson, Roger, Ginis, John, Srivastava, Amit, Perez, John L.
Publicado 2020

Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial

por Thomas, Stephen J., Perez, John L., Lockhart, Stephen P., Hariharan, Subramanian, Kitchin, Nicholas, Bailey, Ruth, Liau, Katherine, Lagkadinou, Eleni, Türeci, Özlem, Şahin, Ugur, Xu, Xia, Koury, Kenneth, Dychter, Samuel S., Lu, Claire, Gentile, Teresa C., Gruber, William C.
Publicado 2022

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents

por Vesikari, Timo, Østergaard, Lars, Diez-Domingo, Javier, Wysocki, Jacek, Flodmark, Carl-Erik, Beeslaar, Johannes, Eiden, Joseph, Jiang, Qin, Jansen, Kathrin U., Jones, Thomas R., Harris, Shannon L., O'Neill, Robert E., York, Laura J., Crowther, Graham, Perez, John L.
Publicado 2016

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

por Frenck, Robert W., Klein, Nicola P., Kitchin, Nicholas, Gurtman, Alejandra, Absalon, Judith, Lockhart, Stephen, Perez, John L., Walter, Emmanuel B., Senders, Shelly, Bailey, Ruth, Swanson, Kena A., Ma, Hua, Xu, Xia, Koury, Kenneth, Kalina, Warren V., Cooper, David, Jennings, Timothy, Brandon, Donald M., Thomas, Stephen J., Türeci, Özlem, Tresnan, Dina B., Mather, Susan, Dormitzer, Philip R., Şahin, Uğur, Jansen, Kathrin U., Gruber, William C.
Publicado 2021

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

por Polack, Fernando P., Thomas, Stephen J., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Perez, John L., Pérez Marc, Gonzalo, Moreira, Edson D., Zerbini, Cristiano, Bailey, Ruth, Swanson, Kena A., Roychoudhury, Satrajit, Koury, Kenneth, Li, Ping, Kalina, Warren V., Cooper, David, Frenck, Robert W., Hammitt, Laura L., Türeci, Özlem, Nell, Haylene, Schaefer, Axel, Ünal, Serhat, Tresnan, Dina B., Mather, Susan, Dormitzer, Philip R., Şahin, Uğur, Jansen, Kathrin U., Gruber, William C.
Publicado 2020

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

por Thomas, Stephen J., Moreira, Edson D., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Perez, John L., Pérez Marc, Gonzalo, Polack, Fernando P., Zerbini, Cristiano, Bailey, Ruth, Swanson, Kena A., Xu, Xia, Roychoudhury, Satrajit, Koury, Kenneth, Bouguermouh, Salim, Kalina, Warren V., Cooper, David, Frenck, Robert W., Hammitt, Laura L., Türeci, Özlem, Nell, Haylene, Schaefer, Axel, Ünal, Serhat, Yang, Qi, Liberator, Paul, Tresnan, Dina B., Mather, Susan, Dormitzer, Philip R., Şahin, Uğur, Gruber, William C., Jansen, Kathrin U.
Publicado 2021